Dr. Ramdev Konijeti, MD

Dr. Konijeti practices at Scripps Green Hospital in La Jolla, California, part of Scripps Health.

Dr. Konijeti's NPI, 1578708715, was assigned on December 2, 2008. Dr. Konijeti graduated from UMKC School of Medicine in 2005. Dr. Konijeti holds California license A100047.

Dr. Konijeti's primary practice is Scripps Green Hospital, at 10666 North Torrey Pines Road, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 554-3600.

Dr. Konijeti's primary practice is Scripps Green Hospital in La Jolla, California, part of Scripps Health. Dr. Konijeti is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Konijeti to 1 more hospital, 1 breast imaging center and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Konijeti practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Konijeti's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Konijeti is board certified in urology by the American Board of Urology. Dmand AI has Dr. Konijeti's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists bladder disease, bladder removal, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease, kidney removal surgery and kidney stone disease among the conditions Dr. Konijeti treats.

CMS data shows 3,887 Medicare services from Dr. Konijeti across 23 procedure codes in 2024, for 859 Medicare patients. Medicare paid $311,021 for them.

CMS counts 859 Medicare patients who saw Dr. Konijeti in 2024. The largest group is 65 to 74, with 383 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Konijeti's median patient age at 69, with 16% women.

In 2024, Dr. Konijeti wrote 1,076 Medicare Part D claims for 333 patients. 94% of them were for generic drugs. CMS names the drug for 976 of them, across 16 drugs with 11 or more claims each, at $85,157 in total drug cost. In 2023, CMS named 1,292 claims across 19 drugs.

Dr. Konijeti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Konijeti as offering telehealth. CMS counts 27 procedures of prostate resection by Dr. Konijeti, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Konijeti, published from 2011 to 2014. 2012 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Robotics. Dr. Konijeti's most frequent co-authors are Pinchas Cohen, MD, Steven Lee Chang, MD, MS and Toni K. Choueiri, MD.

CMS Open Payments shows 293 general payments to Dr. Konijeti from 57 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Pfizer Inc. paid the most, $10,673.

Dr. Konijeti graduated from UMKC School of Medicine in 2005.

Dr. Konijeti is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.